» Articles » PMID: 33548184

COVID-19 Vaccination for People with Severe Mental Illness: Why, What, and How?

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2021 Feb 6
PMID 33548184
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Psychiatric disorders, and especially severe mental illness, are associated with an increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19-related morbidity and mortality. People with severe mental illness should therefore be prioritised in vaccine allocation strategies. Here, we discuss the risk for worse COVID-19 outcomes in this vulnerable group, the effect of severe mental illness and psychotropic medications on vaccination response, the attitudes of people with severe mental illness towards vaccination, and, the potential barriers to, and possible solutions for, an efficient vaccination programme in this population.

Citing Articles

COVID-19 in patients with severe mental illness: An analysis of in-patients at a psychiatric hospital in Cape Town.

Sablay H, Cossie Q, Pieterse D S Afr J Psychiatr. 2025; 31:2286.

PMID: 39968316 PMC: 11830877. DOI: 10.4102/sajpsychiatry.v31i0.2286.


Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort study.

Everest L, Henderson J, Ma C, Prebeg M, Relihan J, Hawke L PLoS One. 2025; 20(1):e0313157.

PMID: 39774518 PMC: 11709255. DOI: 10.1371/journal.pone.0313157.


Perspectives regarding COVID-19 vaccination among unvaccinated persons with mental illness.

Saroja Shankarappa A, Gopalakrishanan R, Packirisamy T, Kuruvilla A Ind Psychiatry J. 2024; 33(Suppl 1):S184-S192.

PMID: 39534157 PMC: 11553621. DOI: 10.4103/ipj.ipj_7_24.


Impact of COVID-19 on Psychiatric Patients: The Role of Vaccination, Comorbidities, and Biomarkers in Clinical Outcomes.

Argyropoulos K, Argyropoulou-Grizanou A, Jelastopulu E J Clin Med. 2024; 13(19).

PMID: 39408010 PMC: 11477535. DOI: 10.3390/jcm13195950.


Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis.

Dang W, Long I, Zhao Y, Xiang Y, Smith R Vaccines (Basel). 2024; 12(9).

PMID: 39340095 PMC: 11436207. DOI: 10.3390/vaccines12091064.


References
1.
Gollust S, Saloner B, Hest R, Blewett L . US Adults' Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019. JAMA Netw Open. 2020; 3(9):e2023020. PMC: 7525353. DOI: 10.1001/jamanetworkopen.2020.23020. View

2.
Brydon L, Harrison N, Walker C, Steptoe A, Critchley H . Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry. 2008; 63(11):1022-9. PMC: 2885493. DOI: 10.1016/j.biopsych.2007.12.007. View

3.
Raaska K, Raitasuo V, Neuvonen P . Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. Eur J Clin Pharmacol. 2002; 57(10):705-8. DOI: 10.1007/s002280100375. View

4.
Miller A . Depression and immunity: a role for T cells?. Brain Behav Immun. 2009; 24(1):1-8. PMC: 2787959. DOI: 10.1016/j.bbi.2009.09.009. View

5.
. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020; 20(7):769-770. PMC: 7239623. DOI: 10.1016/S1473-3099(20)30426-6. View